Article
A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
Leukemia & lymphoma - 1 Jun 2020
Castillo Jorge J, Itchaki Gilad, Gustine Joshua N, Meid Kirsten, Flynn Catherine A, Demos Maria G, Guerrera Maria L, Jimenez Cristina, Kofides Amanda, Liu Xia, Munshi Manit, Tsakmaklis Nicholas, Patterson Christopher J, Xu Lian, Yang Guang, Hunter Zachary R, Treon Steven P
Abstract excerpt
Cases of non-IgM lymphoplasmacytic lymphoma (LPL) are rare. We performed a case-control study comparing features and outcomes of 31 non-IgM LPL cases and 93 Waldenström macroglobulinemia (WM) controls matched by age, sex, and year of diagnosis. Odds of MYD88 mutations were lower (odds ratio (OR) 0.22, p = .05), and median time to treatment was shorter in cases than in controls (4 vs. 32 months; p < .001). Odds of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.